Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Imaging Immune Activation in COVID-19

NCT04815096 is registered in ClinicalTrials.gov with CellSight Technologies, Inc. as lead sponsor.

NCT NCT04815096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04815096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Imaging Immune Activation in COVID-19
Lead sponsor
CellSight Technologies, Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
April 15, 2021
Completion date
October 1, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars-cov infection